Medicinal products are substances that are used to treat diseases, to relieve complaints, or to prevent such diseases or complaints in the first place.
More
Research at the BfArM concentrates on important and contemporary research focal points with regard to the marketing authorisation of medicinal products and improving the safety thereof as well as concerning the recording and assessment of risks in connection with medical devices.
More
(Medicinal products are substances that are used to treat diseases, to relieve complaints, or to prevent such diseases or complaints in the first place.
More
Medicinal products containing sonidegib are embryotoxic and/or teratogenic and can cause embryo-foetal death or severe birth defects when administered to pregnant women; therefore, Odomzo® …
The Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency (EMA) is recommending new restrictions to avoid exposure of babies to valproate in the womb; babies …
The Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency (EMA) has recommended revoking the marketing authorisations of painkillers containing flupirtine.
The German Cardiac Society (DGK) has published recommendations regarding patients with silicone insulated defibrillation leads Riata and Riata ST of St. Jude Medical.